Sabaa International Company for Pharmaceutical and Chemical Industry Share Price

Equities

SIPC

EGS382M1C011

Pharmaceuticals

End-of-day quote Egyptian Exchange 23:00:00 29/04/2024 BST 5-day change 1st Jan Change
0.68 EGP -.--% Intraday chart for Sabaa International Company for Pharmaceutical and Chemical Industry -3.13% -14.79%

Financials

Sales 2022 18.2M 380K 30.4M Sales 2023 13.31M 278K 22.23M Capitalization 200M 4.16M 333M
Net income 2022 - 0 0 Net income 2023 - 0 0 EV / Sales 2022 16.6 x
Net Debt 2022 20.49M 428K 34.23M Net Debt 2023 20.01M 418K 33.42M EV / Sales 2023 16.5 x
P/E ratio 2022
19,379 x
P/E ratio 2023
1,765 x
Employees 165
Yield 2022 *
-
Yield 2023
-
Free-Float 16.69%
More Fundamentals * Assessed data
Dynamic Chart
Sabaa International Company for Pharmaceutical and Chemical Industry Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Sabaa International Company for Pharmaceutical and Chemical Industry Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Sabaa International Company for Pharmaceutical and Chemical Industry Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Sabaa International Company for Pharmaceutical and Chemical Industry Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Sabaa International Company for Pharmaceutical and Chemical Industry Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Sabaa International Company for Pharmaceutical and Chemical Industry Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Sabaa International Company for Pharmaceutical and Chemical Industry Declares A Stock Dividends, Payable on October 19, 2021 CI
Sabaa International Company for Pharmaceutical and Chemical Reports Earnings Results for the Six Months Ended June 30, 2021 CI
Sabaa International Company for Pharmaceutical and Chemical Industry Reports Earnings Results for the Quarter Ended March 31, 2021 CI
Sabaa International Company for Pharmaceutical and Chemical Industry announced that it expects to receive EGP 12 million in funding CI
Sabaa International Company for Pharmaceutical and Chemical Industry Reports Earnings Results for the First Quarter Ended March 31, 2019 CI
Sabaa International Company for Pharmaceutical and Chemical Industry Announces Audited Earnings Results for the Year Ended December 31, 2018 CI
Sabaa International Company for Pharmaceutical and Chemical Announces Earnings Results for the Nine Months Ended September 30, 2018 CI
Sabaa International Company for Pharmaceutical and Chemical Industry Announces Earnings Results for the Six Months Ended June 30, 2018 CI
Sabaa International Company for Pharmaceutical and Chemical Industry Reports Earnings Results for the First Quarter Ended March 31, 2018 CI
More news
1 week-3.13%
Current month-4.63%
1 month-4.63%
3 months-20.37%
6 months-10.76%
Current year-14.79%
More quotes
1 week
0.62
Extreme 0.615
0.72
1 month
0.62
Extreme 0.615
0.76
Current year
0.62
Extreme 0.615
0.95
1 year
0.62
Extreme 0.615
1.17
3 years
0.62
Extreme 0.615
1.51
5 years
0.40
Extreme 0.4004
1.51
10 years
0.28
Extreme 0.2789
1.51
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member - -
Chief Executive Officer - -
Director/Board Member - -
More insiders
Date Price Change Volume
01/05/24 0.68 -.--% 232,151
30/04/24 0.68 -.--% 384,430
29/04/24 0.68 -.--% 544,507
28/04/24 0.68 -.--% 244,498
24/04/24 0.68 -3.13% 551,100

End-of-day quote Egyptian Exchange, April 29, 2024

More quotes
Sabaa International Company for Pharmaceutical and Chemical S.A.E specializes in the research, development and manufacturing of generic pharmaceuticals, cosmetics and nutraceuticals. Besides, the group offers subcontracted manufacturing services to third parties.
More about the company